Baxter International Inc.

NYSE:BAX

Sector

🏥 Health Care

Industries

🏥 Hospitals & Clinics

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 14.99 B

Share Price

USD 29.22

Avg Daily Volume

4,001,175

Change (1 day)

1.56%

Change (1 year)

-16.73%

Change (YTD)

0.21%

Baxter International Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.02 B

Baxter International Inc. EBITDA is USD 1.02 B for the Trailing 12 Months (TTM) ending March 31, 2025, a -38.31% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Baxter International Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 1.66 B, a -303.57% change year over year.
Baxter International Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -813.00 M, a -132.13% change year over year.
Baxter International Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.53 B, a 11.65% change year over year.
Baxter International Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 2.27 B, a 20.92% change year over year.